Atlas Trials

Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

Clinical trial NCT03977480 · TERMINATED

Trial details

NCT number
NCT03977480
Sponsor
Tianjin Hemay Pharmaceutical Co., Ltd
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2019-08-13
Primary completion
2022-08-12
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.